Plain-English translation of NCT07232433 on ClinicalTrials.gov โ ยท
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing cryoablation, a minimally invasive procedure that uses extreme cold to destroy lung nodules (small spots detected on imaging). The study will enroll 90 patients who have nodules that are too small or who are too frail for traditional surgery, to see whether cryoablation is safe and effective over 2 to 5 years.
Many people with early lung nodules are found through screening scans, but cannot have surgery because of age, heart or lung problems, or other health issues. This treatment offers a less invasive option, but doctors need better evidence that it works well and is safe long-term.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive the cryoablation procedure, which involves either passing a scope down your breathing tube or using a small needle guided by imaging to deliver freezing cold to destroy the nodule. After the procedure, you would be monitored in the hospital and then followed with imaging scans over 2 to 5 years to track whether the nodule stays gone and whether you have any complications. The study will measure how well the procedure works, whether you recover your lung function, your pain levels, and how long you stay in the hospital.
AI-generated summary from trial data ยท Aug 14, 2026 ยท Not medical advice
China